Clofazimine (as part of an optimized background regimen for MDR-TB)
Treatment used for 1 condition
Total Trials
40
Total Participants
7K
Avg Effectiveness
70%
Avg Safety Score
70%
Conditions Treated
Click on a condition to view detailed treatment information and clinical trial data.